Substance use outcomes following treatment: Findings from the Australian Patient Pathways Study

The Australian and New Zealand Journal of Psychiatry
Victoria ManningDan I Lubman

Abstract

Our understanding of patient pathways through specialist Alcohol and Other Drug treatment and broader health/welfare systems in Australia remains limited. This study examines how treatment outcomes are influenced by continuity in specialist Alcohol and Other Drug treatment, engagement with community services and mutual aid, and explores differences between clients who present with a primary alcohol problem relative to those presenting with a primary drug issue. In a prospective, multi-site treatment outcome study, 796 clients from 21 Alcohol and Other Drug services in Victoria and Western Australia completed a baseline interview between January 2012 and January 2013. A total of 555 (70%) completed a follow-up assessment of subsequent service use and Alcohol and Other Drug use outcomes 12-months later. Just over half of the participants (52.0%) showed reliable reductions in use of, or abstinence from, their primary drug of concern. This was highest among clients with meth/amphetamine (66%) as their primary drug of concern and lowest among clients with alcohol as their primary drug of concern (47%), with 31% achieving abstinence from all drugs of concern. Continuity of specialist Alcohol and Other Drug care was associated with hi...Continue Reading

References

Jan 27, 1996·Lancet·C P O'Brien, A T McLellan
Aug 1, 1996·Alcoholism, Clinical and Experimental Research·H M PettinatiJ M Jensen
Dec 12, 1982·Evaluation and Program Planning·T D NguyenB L Stegner
Oct 4, 2000·JAMA : the Journal of the American Medical Association·A T McLellanH D Kleber
Sep 29, 2004·Journal of Substance Abuse Treatment·D Dwayne Simpson
Mar 1, 2005·Addiction·Deborah A DawsonW June Ruan
Dec 14, 2005·Drug and Alcohol Dependence·Maree TeessonRichard Cooke
Dec 6, 2007·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Tom Calma
Feb 23, 2008·Addiction Science & Clinical Practice·Michael Dennis, Christy K Scott
Jun 11, 2008·International Journal of Methods in Psychiatric Research·Thomas F BaborAnders Romelsjo
Jan 24, 2009·Journal of Substance Abuse Treatment·James R McKayJohn Schwartzlose
Jan 24, 2009·Journal of Substance Abuse Treatment·William L White
Apr 3, 2009·Journal of Addictive Diseases·Lee Ann Kaskutas
Oct 5, 2011·Psychiatric Services : a Journal of the American Psychiatric Association·Felicia W ChiConstance M Weisner
Jan 24, 2012·Addiction Biology·Katherine StavroStéphane Potvin
Nov 6, 2012·Drug and Alcohol Dependence·John F KellyValerie Slaymaker
Dec 10, 2013·Drug and Alcohol Dependence·Evelien LenaertsBert Aertgeerts

❮ Previous
Next ❯

Citations

Jun 2, 2016·Addiction·Jenny ChalmersLynda Berends
Oct 25, 2016·Australian and New Zealand Journal of Public Health·Tina LamSteve Allsop
Apr 9, 2017·Substance Abuse Treatment, Prevention, and Policy·Michael SavicDan I Lubman
Oct 27, 2018·Revista brasileira de enfermagem·Gabriella de Andrade BoskaPaula Hayasi Pinho
Nov 1, 2018·Journal of Addiction Medicine·Chloe LanyonBrendan Quinn
Sep 11, 2019·Journal of Clinical Medicine·Victoria ManningDan I Lubman
Feb 11, 2020·Frontiers in Psychiatry·Volker BöckmannBenedikt Habermeyer
Mar 28, 2021·Journal of Substance Abuse Treatment·Richard RawsonDavid Farabee
May 29, 2021·Drug and Alcohol Review·Sarah J MacLeanJoanne Bryant
May 22, 2021·Health Sociology Review : the Journal of the Health Section of the Australian Sociological Association·Adrian FarrugiaAnnie Madden
Sep 18, 2021·Health & Social Care in the Community·Gabriella de Andrade BoskaPaulo R Carvalho Seabra
Oct 4, 2021·The Medical Journal of Australia·Paul S HaberKirsten C Morley

❮ Previous
Next ❯

Methods Mentioned

BETA
Pharmacotherapies
pharmacotherapy

Software Mentioned

MATES
ATOS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.